CD4 and breast cancer: To further analyze the correlation between CD4+AC and clinicopathological parameters, we used the median of CD4+AC (451 cells/μL) as the cutoff value and divided 237 BC patients into low level (<451 cells/μL) (118 cases) and high level (<451 cells/μL) (119 cases.